# Estimation of global insulin utilization for type 2 diabetes mellitus, 2018 to 2030

Sanjay Basu1,2*, John S. Yudkin3, Sylvia Kehlenbrink4, Justine Davies5, Sarah H. Wild6, Kasia J. Lipska7, Jeremy B. Sussman8,9, David Beran10

1 Center for Primary Care and Outcomes Research and Center for Population Health Sciences, Departments of Medicine and of Health Research and Policy, Stanford University
2 Center for Primary Care, Harvard Medical School
3 Institute of Cardiovascular Science, Division of Medicine, University College London
4 Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Womenâ€™s Hospital
5 Department of Global Health, Birmingham University
6 Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
7 Department of Internal Medicine, Section of Endocrinology, Yale School of Medicine
8 Division of General Medicine, University of Michigan
9 Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System
10 Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals

*Email: basus@stanford.edu
